Published in Diabetes on March 01, 1990
Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet (1998) 3.71
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J Biol Chem (1971) 3.52
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. J Biol Chem (1971) 3.13
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group. Diabet Med (1994) 2.78
Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg (2001) 2.39
[Thyroid function, activities of daily living and survival in extreme old age: the 'Leiden 85-plus Study']. Ned Tijdschr Geneeskd (2006) 2.11
C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol (2000) 1.70
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. J Biol Chem (1971) 1.68
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer (1994) 1.59
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. J Hypertens (2001) 1.51
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab (2001) 1.51
Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth J Med (2007) 1.48
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
[The immune system and Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.38
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. VI. Evidence for a role of membrane lipids. J Biol Chem (1971) 1.36
Inflammation and stroke: the Leiden 85-Plus Study . Stroke (2002) 1.29
Inactivation of glucagon by plasma membranes of rat liver. J Biol Chem (1972) 1.20
Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology (2003) 1.15
beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man. Br J Clin Pharmacol (1995) 1.14
The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab (2002) 1.11
Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab (1993) 1.10
An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab (1996) 1.10
Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case. Neth J Med (1996) 1.10
Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab (2010) 1.09
Low innate production of interleukin-1beta and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage (2010) 1.06
Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord (1992) 1.03
Glucose as a regulator of insulin-sensitive hexose uptake in 3T3 adipocytes. J Biol Chem (1985) 1.03
Management of type 2 diabetes: a challenge for patient and physician. Patient Educ Couns (2000) 1.03
Does jejunal feeding activate exocrine pancreatic secretion? Eur J Clin Invest (1999) 1.02
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism (1993) 1.02
Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience (2004) 1.01
Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia (2006) 1.01
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia (1997) 1.00
Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients. Eur J Endocrinol (2004) 1.00
Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab (2001) 0.99
Activation of the Ras/mitogen-activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes. Mol Cell Biol (1994) 0.98
Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. Eur J Endocrinol (2005) 0.97
Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis (2000) 0.96
Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab (1997) 0.96
The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin Endocrinol (Oxf) (1999) 0.96
Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia. Am Rev Respir Dis (1993) 0.95
Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol (Oxf) (2006) 0.95
Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease. Eur J Endocrinol (1997) 0.94
Performance of the whole-blood stimulation assay for assessing innate immune activation under field conditions. Cytokine (2009) 0.94
Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol (1998) 0.92
Blood glucose awareness training in Dutch type 1 diabetes patients: one-year follow-up. Neth J Med (2005) 0.92
Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2005) 0.92
Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease. J Neuroendocrinol (2011) 0.90
Predictive value of tetrapolar body impedance measurements for hydration status in critically ill patients. Intensive Care Med (1995) 0.89
Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels. Neurology (2009) 0.89
Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab (2004) 0.89
Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrinol (1999) 0.88
A mutation in the insulin receptor that impairs proreceptor processing but not insulin binding. J Biol Chem (1994) 0.88
Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients. Int J Obes Relat Metab Disord (1992) 0.88
A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochemistry (1991) 0.88
Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia (1991) 0.88
Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr Metab (2003) 0.88
Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed (2008) 0.88
Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation. Diabetes (1989) 0.87
Cesarean section combined with splenectomy in a parturient with immune thrombocytopenic purpura. J Clin Anesth (2001) 0.87
Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia. Scand J Gastroenterol (1998) 0.86
Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab (1998) 0.86
Reduced glucose transport and increased binding of insulin in adipocytes from diabetic and fasted rats. Biochim Biophys Acta (1978) 0.86
Hypoxic syncope. Aviat Space Environ Med (1997) 0.86
The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin Physiol Funct Imaging (2002) 0.85
A leucine-to-proline mutation in the insulin receptor in a family with insulin resistance. EMBO J (1989) 0.85
Growth hormone secretion in recently operated acromegalic patients. J Clin Endocrinol Metab (1994) 0.85
Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabet Med (2001) 0.84
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Eur J Neurol (2009) 0.84
Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome. Clin Endocrinol (Oxf) (1994) 0.84
Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. J Clin Endocrinol Metab (1998) 0.84
The surgical approach to the adrenal gland: a comparison of the retroperitoneal and the transabdominal routes in 326 operations on 284 patients. Jpn J Clin Oncol (2000) 0.84
Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol (Oxf) (1985) 0.83
A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab (2000) 0.83
The effect of insulin, serum and dexamethasone on mRNA levels for the insulin receptor in the human lymphoblastoic cell line IM-9. Biochim Biophys Acta (1987) 0.83
Psychological and metabolic responses of carbohydrate craving obese patients to carbohydrate, fat and protein-rich meals. Int J Obes Relat Metab Disord (1997) 0.83
Serum levels of unconjugated aetiocholanolone androstenedione, testosterone, dehydroepiandrosterone, aldosterone, progesterone and oestrogens during the normal menstrual cycle. Acta Endocrinol (Copenh) (1976) 0.83
Alterations in calcium metabolism in young people at risk for primary hypertension. The Dutch Hypertension and Offspring Study. Hypertension (1993) 0.83
Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. Early Hum Dev (2001) 0.83
Long-term results of total adrenalectomy for Cushing's disease. World J Surg (2000) 0.83
The effects of duct obliteration and of autotransplantation on the endocrine function of canine pancreatic segments. Diabetes (1985) 0.83
Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption. J Clin Endocrinol Metab (1996) 0.83
Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands. J Clin Endocrinol Metab (1995) 0.82
Endocrine functions in Huntington's disease. A two-and-a-half years follow-up study. J Neurol Sci (1989) 0.82
Phloretin - an uncoupler and an inhibitor of mitochondrial oxidative phosphorylation. Biochim Biophys Acta (1983) 0.82
An Arg for Gly substitution at position 31 in the insulin receptor, linked to insulin resistance, inhibits receptor processing and transport. J Biol Chem (1992) 0.82
Increased insulin action and clearance in hyperthyroid newly diagnosed IDDM patient. Restoration to normal with antithyroid treatment. Diabetes Care (1989) 0.82
Impact of meal timing and frequency on the twenty-four-hour leptin rhythm. Horm Res (2004) 0.82
Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome. J Clin Endocrinol Metab (2004) 0.82